Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes

Medical Science Monitor

Volumn 11, Issue 7, 2005, Pages

  Somogyi, Anikó ^a,b   Ruzicska, Éva ^a   Blázovics, Anna ^a   Vér, Ágota ^a   Rosta, Klára ^a   Tóth, Miklós ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANTIOXIDANT; CARBOHYDRATE; CHOLESTEROL; FRUCTOSAMINE; GLUCOSE; INSULIN; SCAVENGER; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HYPERGLYCEMIA; INSULIN TREATMENT; MALE; NONHUMAN; OXIDATIVE STRESS; PARAMETER; RAT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; HEART VENTRICLES; HYPERTROPHY, LEFT VENTRICULAR; HYPOGLYCEMIC AGENTS; INSULIN; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 22244466785     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hattori Y, Suzuki M, Hattori S, Kasai K: Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension, 2002; 39: 22-28
2. Vanderjagt DJ, Harrison JM, Ratliff DM et al: Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clinical Biochemistry, 2001; 34: 265-70
3. Sadoshima J, Izumo S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circulation Research, 1993; 73(3), 413-23
4. Dhalla NS, Liu X, Panagia V, Takeda N: Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovascular Research, 1998; 40(2): 239-47
5. Hebden RA, Gardiner SM, Bennett T, MacDonald IA: The influence of streptozotocin-induced diabetes mellitus on fluid and electrolyte handling in rats. Clinical Science (Colch), 1986; 70: 111-17
6. Sowers RJ, Epstein M, Frohlich ED: Diabetes, hypertension, and cardiovascular disease. An update. Hypertension, 2001; 37: 1053-59
7. Mathis DR, Liu SS, Rodrigues BB, McNeill JH: Effect of hypertension on the development of diabetic cardiomyopathy. Canadian Journal Physiology, 2000; 78(10): 791-98
8. Blázovics A, Kovács A, Lugasi A et al: Antioxidant defence in erythrocytes and plasma of patients with active and quiescent Crohn disease and ulcerative colitis: A chemiluminescent study. Clinical Chemistry, 1999; 45: 895-96
9. Foldes G, Suo M, Szokodi I et al: Factors derived from adrenals are required for activation of cardiac gene expression in angiotensin II-induced hypertension. Endocrinology, 2001; 142: 4256-63
10. th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 3. Spectrum of risk factors for coronary heart disease. Journal of American College. Cardiology, 1996; 27: 978-90
11. Kishore JH: Potential new cardiovascular risk factors: Left ventricular hypertrophy, homocysteine, Lipoprotein(a), triglicerides, oxidative stress, and fibrinogen. Annals of Internal Medicine, 1999; 131(5): 376-86
12. Ceriello A: Mechanisms of tissue damage in the postprandial state. Int J Clin Pract, 2001; Suppl. 123: 7-12
13. Korantzopoulos P, Galaris D, Papaioannides D, Siogas K: The possible role of oxidative stress in heart failure and the potential of antioxidant intervention. Med Sci Monit, 2003; 9(6): RA140-RA145
14. Marfella R, Quagliaro L, Nappo F et al: Acute hyperglycemia induces an oxidative stress in healthy subjects. Journal of Clinical Investigation, 2001; 108(4): 635-36
15. Krauss H, Kozlik J, Grzymislawski M et al: The influence of glimepiride on the oxidative state of rats with streptozotocin-induced hyperglycemia. Med Sci Monit, 2003; 9(11): BR389-BR393
16. Noberasco C, Odetti P, Maiello BM, Adezati L: Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin. Biomedicine and Pharmacotherapy, 1991; 45: 193-96
17. Jain SK, Levine SN, Duett J, Hollier B: Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism Clinical and Experimental, 1990; 39(9): 971-75
18. Jain SK, Levine SN, Duettand J, Hollier B: Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats. Diabetes, 1991; 40, 1241-44
19. Cai L, Kang YJ: Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol, 2001; 1: 181-93
20. Singal PK, Bello-Klein A, Farahmand F, Sandhawalia V: Oxidative stress and functional deficit in diabetic cardiomyopathy. Adv Exp Med Biol, 2001; 498: 213-20
21. Giugliano D, Ceriello A, Paolisso: Diabetes mellitus, hypertension and cardiovascular disease: Which role for oxidative stress? Metabolism, 1995; 44: 363-68
22. Rosen PT, Ballhausen T, Bloch W, Addicks K: Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia, 1995; 38: 1157-68
23. Duckworth WC: Hyperglycemia and cardiovascular disease. Current Atherosclerosis Report, 2001; 3(5): 383-91
24. Lipinski B: Pathophysiology of oxidative stress in diabetes mellitus. Journal Diabetes Complications, 2001; 15(4): 203-10
25. Ceriello A: Mechanisms of tissue damage in the postprandial state. International Journal of Clinical Practice, 2001; Suppl. 123: 7-12
26. Stout RW: Insulin and atheroma: a 20-year perspective. Diabetes Care. 1990; 13: 631-54
27. Mikhail N, Tuck ML: Insulin and the vasculature. Curr Hypertens Re. 2000; 2: 148-53
28. Steinberg HO, Chaker H, Leaming R et al: Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest, 1996; 97: 2601-10
29. Kubes P, Suzuki M, Granger DN: Nitric oxide: an endogenous modula-tor of leukocyte adhesion. Proc Natl Acad Sci USA, 1991; 88: 4651-55
30. Lloyd-Jones DM, Bloch KD: The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med, 1996; 47: 365-75
31. Zeng G, Nystrom FH, Ravichandran LV et al: Roles of insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation, 2000; 101: 1539-45
32. Arcaro G, Zamboni M, Rossi L et al: Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord, 1999; 23: 936-42
33. Cai H, Harrison DG et al: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 2000; 87: 840-44
34. Cardillo C, Nambi SS, Kilcoyne CM et al: Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation, 1999; 100: 820-25
35. Kashiwagi A, Shinozaki K, Nishio Y et al: Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol, 1999; 277: E976-E983
36. Valkonen M, Kuusi T: Spectrophotometric assay for total peroxyl radical-trapping antioxidant potential in human serum. Journal Lipid Research, 1997; 38: 823-33
37. Harjai, Kishore JH: Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerids, oxidative stress and fibrinogen, Annals of Internal Medicine, 1999; 131(5): 376-86
38. Dzau VJ: Cardiac renin-angiotensin system. Molecular and functional aspects. Am J Med, 1988; 84: 22-27
39. Baker KM, Chernin MI, Wixson SK, Aceto JF: Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol, 259: H324-H332